MTM1 and X-linked myotubular myopathy: The ASPIRO trial enrolled 24 boys with X-linked myotubular myopathy who were on mechanical ventilatory support for treatment with an AAV8 delivering the human MTM1 transgene (1.3–3 × 1014 vg/kg).